Skip to main content
. Author manuscript; available in PMC: 2023 May 21.
Published in final edited form as: Endocr Pract. 2022 Aug 11;28(10):923–1049. doi: 10.1016/j.eprac.2022.08.002

Table 6.

Glycemic Targets for Persons with Diabetes Mellitus

Parameter Treatment goal
Glucose
A1C, % Individualize on the basis of age, comorbid conditions, duration of disease; in general, ≤6.5 for most; closer to normal for healthy; less stringent for those at greater risk for hypoglycemia and/or adverse consequences from hypoglycemia; longer duration of diabetes; shorter life expectancy; comorbidities especially established vascular complications
FPG, mg/dL <110
2-h PPG, mg/dL <140
Inpatient hyperglycemia: glucose, mg/dL 140 to 180
Weight
Weight loss Reduce weight by >5% to ≥10%; avoid weight gain
Diabetes type Glucose range a,179 Recommendations (% of readings)
T1D and T2D <54 mg/dL (<3.0 mmol/L) <1%
<70 mg/dL (<3.9 mmol/L) <4%
70 to 180 mg/dL (3.9 to 10.0 mmol/L) >70%
>180 mg/dL (>10.0 mmol/L) <25%
>250 mg/dL (>13.9 mmol/L) <5%
Pregnancy with T1D <54 mg/dL (<3.0 mmol/L) <1%
<63 mg/dL (<3.5 mmol/L) <4%
63 to 140 mg/dL (3.5 to 7.8 mmol/L) >70%
>140 mg/dL (>7.8 mmol/L) <25%
Pregnancy with gestational or T2D 63 to 140 mg/dL (3.5 to 7.8 mmol/L) >90%

Abbreviations: A1C = hemoglobin A1c; FPG = fasting plasma glucose; PPG = postprandial glucose; T1D = type 1 diabetes; T2D = type 2 diabetes

a

Downloaded from CGM preferably, or other devices if CGM not available.